hsa-miR-1283: Hsa-mir-1283 is a microRNA molecule that has been identified in various studies and datasets. It is a member of the miR-1283 family and has been found to be associated with essential hypertension [PMC6746216]. It has also been shown to potentially regulate the expression of ATF1, a gene that is abnormally expressed in essential hypertension [PMC6746216]. Additionally, hsa-mir-1283 has been predicted to target the 5ʹUTR of the SARS-CoV-2 genome, suggesting its potential role in viral infection [PMC8527307]. Furthermore, hsa-mir-1283 has been linked to onco-protective roles and inhibition of apoptosis, indicating its potential involvement in cancer development [PMC9459146]. The ATF1 rs11169571 variant has been shown to alter the binding site of hsa-mir-1283 and increase susceptibility to colorectal cancer [PMC9688512]. The hsa-mir-1283 cluster, which includes several miRNAs such as hsa-miR-320a and hsa-miR-374a, is characterized by a high enrichment in flanking Alu sequences and may have co-evolved with the miR cluster [PMC3926826]. Hsa-mir-1283 expression has also been found to be significantly different between pregnant and non-pregnant women [PMC8759232]. In various datasets related to different conditions such as cardiovascular disease and colorectal cancer, differential expression of hsa-mir-1283 has been observed [PMC8923688] [PMC7453507] [PMC4159370] [PMC9814319].